HIKMA Pharmaceuticals PLC — Director's Dealing 2017

Apr 28, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7325D

Hikma Pharmaceuticals Plc

28 April 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 19,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)	Price(s) and volume(s)	Price(s): £19.36 Volume(s): 19,500
d)	Aggregated information	Volume: 19,500 Price: £19.36 Total: £377,520.00
e)	Date of the transaction	28 April 2017
f)	Place of the transaction	London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBXGDSIBDBGRI